Speaker Profile
M.D., Ph.D., Co-Founder and Chief Scientific Officer, Genomenon
Biography
Dr. Mark Kiel completed his M.D., Ph.D., and Molecular Genetic Pathology Fellowship at the University of Michigan, where his research focused on stem cell biology, genomic profiling of hematopoietic malignancies, and clinical bioinformatics. He is the founder and chief scientific officer at Genomenon, a genomic intelligence company, where he oversees the company's scientific direction and product development. Mark founded Genomenon in 2014 to address the challenge of connecting researchers with evidence in the genomic literature to help diagnose and treat patients with genetic diseases and cancer.
Talk
Unlocking Genomic Insights: Harnessing AI for Breakthroughs
Dr. Mark Kiel discusses the challenges of integrating AI in genomics and its transformative possibilities. With AI-driven analysis of comprehensive genomic data, researchers can uncover hidden patterns, predict disease trajectories, and personalize treatments, pushing forward the frontiers of genomic intelligence.
AI and Data Sciences Showcase:
Genomenon
Genomenon is a genomic intelligence company transforming patient care by uncovering the genomic drivers of genetic disease and cancer. By combining the power of AI built on the world’s premier genomic data set with genomic expertise, the company simplifies complex genetic data into actionable insights.
Session Abstract – PMWC 2025 Silicon Valley
The PMWC 2025 AI Company Showcase will provide a 15-30 minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
